维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="Giessmann W"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘	Weitschies W Bernsdorf A Giessmann T	2005	Pharm Res2005，22，5：	1
	2	The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘	Weitschies W Bernsdorf A Giessmann T	2005	Pharm Res2005，22，5：	1
	3	The oral, once- daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide 显示文摘	Hermann R Siegmund W Giessmann T	2007	J Clin Pharmacol2007，47，8：	1
	4	Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging显示文摘	Schiller C P Frohlich T Giessmann W	2005	Aliment Pharmacol Ther2005，22，：	1
	5	The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gutlumen显示文摘	Weitschies W Bernsdorf A Giessmann T	2005	Pharm Res2005，22，5：	1
	6	The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘	Bernsdorf A Giessmann T	2005	Pharm Res2005，22，5：	1
	7	The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and dis- position of the probe drug talinolol 显示文摘	Siegmund W Ludwig K Giessmann T	2002	Clin Pharmacol Ther2002，72，5：	1
	8	Microinjection of actin antibodies impaired gap junctional intercellular communication in lensepithelial cells in vitro 显示文摘	Giessmann D Theiss C Breipohl W	2003	Curr Eye Res2003，27，3：	1
	9	The talinolol double-peak phenomenon is likely caused by presyst- emic processing after uptake from gut lumen显示文摘	WEITSCHIES W BERNSDORF A GIESSMANN T et (d	2005	Pharm Res2005，22，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费